TNNI3 and acute myocardial infarction: Accordingly, measurement of cTnI level is part of a clinical risk assessment which enables early diagnosis, prognosis, and monitoring of acute myocardial infarction (AMI) with a cTnI level of 0.4 ng/mL or greater considered indicative of an AMI9–11.